Statistics on Biotechnology Use Total Sectors Biotechnology indicators by execution sector. Unidades: Specified in each variable Total Companies Public Administration Higher Education NPPI Units carrying out R&D in Biotechnology 1.636 113 68 1.444 11 % Units by type of biotechnology used: Genetic Code 37,2 87,6 94,1 30,7 27,3 % Units by type of biotechnology used: Functional Units 43,5 86,7 95,6 37,6 54,5 % Units by type of biotechnology used: Cell and Tissue Culture and Engineering 27,6 72,6 80,9 21,3 63,6 % Units by type of biotechnology used: Bioprocesses 53,6 65,5 91,2 50,9 54,5 % Units by type of biotechnology used: Subcellular Organisms 13,9 55,8 64,7 8,1 36,4 % Units by type of biotechnology used: Bioinformatics 28,7 71,7 83,8 22,6 36,4 % Units by type of biotechnology used: Nanobiotechnology 15,5 53,1 73,5 9,8 18,2 % Units by type of biotechnology used: Other 15,7 7,1 7,3 16,9 9,1 Units in which biotechnology activities are: Main and/or exclusive 676 35 5 629 7 Units in which biotechnology activities are: A secondary business line 347 36 47 262 2 Units in which biotechnology activities are: A necessary tool for production 613 42 16 553 2 % Units by final application areas of biotechnology use: Human Health 48,7 76,1 92,7 44,3 72,7 % Units by final application areas of biotechnology use: Animal Health and Aquaculture 17,8 18,6 61,8 15,8 9,1 % Units by final application areas of biotechnology use: Food Products 32,4 26,6 82,3 30,7 0 % Units by final application areas of biotechnology use: Agriculture and Forestry 26,4 21,2 67,7 24,9 18,2 % Units by final application areas of biotechnology use: Environment 19,8 23,9 75 16,9 9,1 % Units by final application areas of biotechnology use: Industry 15,2 18,6 66,2 12,6 9,1 R&D personnel in Biotechnology (PP) 50.084 15.563 16.597 17.743 181 R&D personnel in Biotechnology (PP): Research personnel 32.396 9.798 13.026 9.445 127 R&D personnel in Biotechnology (PP): Technical and auxiliary personnel 17.688 5.765 3.571 8.298 54 R&D personnel in Biotechnology (PP). Women 28.401 9.804 8.578 9.907 112 R&D personnel in Biotechnology (PP). Women: Research personnel 17.461 5.851 6.435 5.104 71 R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel 10.939 3.953 2.143 4.802 41 R&D personnel in Biotechnology (FTE) 35.301,2 11.442,1 10.721,9 12.993,4 143,8 R&D personnel in Biotechnology (FTE): Research personnel 22.324,6 6.766,8 8.386,7 7.069,9 101,2 R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel 12.976,7 4.675,3 2.335,2 5.923,6 42,6 R&D personnel in Biotechnology (FTE). Women 20.474,8 7.280,8 5.633,9 7.471,8 88,3 R&D personnel in Biotechnology (FTE). Women: Research personnel 12.176,5 4.080,5 4.171,9 3.870,1 54 R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel 8.298,2 3.200,3 1.462 3.601,6 34,3 Expenditure on internal R&D in Biotechnology (thousands of euros) 2.565.367 775.164 554.906 1.223.801 11.496 1) By type of expenditure: Current expenditure 2.359.528 727.099 513.043 1.108.189 11.197 1.1) Labour expenditure of research personnel 950.162 267.235 318.977 360.922 3.027 1.2) Labour expenditure of technical and auxiliary personnel 421.784 128.800 71.268 220.540 1.176 1.3) Other current expenditure 987.583 331.063 122.798 526.727 6.994 2) By type of expenditure: Capital expenditure 205.839 48.066 41.862 115.612 299 2.1) Land and buildings 30.577 6.521 7.162 16.843 52 2.2) Equipment and tools 136.544 39.416 33.362 63.527 239 2.3) Acquisition of specific R&D software 7.117 1.945 1.211 3.959 3 2.4) Other R&D-specific IP products 31.601 184 128 31.284 5 1.1) By origin of funds: Own funds 1.030.214 78.546 90.048 860.603 1.016 1.2) By origin of funds: Funds from the Business sector 277.770 115.144 27.808 128.002 6.816 1.3) By origin of funds: Funds from the Public Administration sector 951.439 458.700 372.119 119.498 1.122 1.4) By origin of funds: Funds from the Higher Education sector 4.307 1.537 2.122 647 0 1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector 52.107 28.686 9.445 12.986 990 1.6) By origin of funds: Funds from the rest of the world 249.530 92.551 53.363 102.065 1.551 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros) 171.660 35.006 13.038 123.396 220 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain 131.863 30.282 12.385 88.985 212 Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world 39.797 4.725 653 34.412 8 % Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital 41,8 57,5 52,9 39,8 72,7 % Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information 14,8 8,8 14,7 15,3 9,1 % Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources 24,5 46 36,8 22,3 18,2 % Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain 13,8 23 35,3 12,1 9,1 % Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets 19 28,3 44,1 17,1 27,3 % Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels 19,4 28,3 38,2 17,8 18,2 % Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception 15,3 10,6 10,3 16 9,1 % Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements 41,3 40,7 39,7 41,4 36,4 % Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost 51,2 62,8 51,5 50,2 63,6 % Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting 20 19,5 19,1 20,1 18,2 Notas: Data referring to all companies and organisations that carry out internal R&D in Biotechnology. 2) ' .'= numeric data equal to zero not resulting from rounding 3) FTE: Full-Time Equivalence Fuente: National Statistics Institute